Download
rccm.202108-1901oc.pdf 2,77MB
WeightNameValue
1000 Titel
  • Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing
1000 Autor/in
  1. Johansen, Matt D. |
  2. Mahbub, Rashad M. |
  3. Idrees, Sobia |
  4. Nguyen, Duc H. |
  5. Miemczyk, Stefan |
  6. Pathinayake, Prabuddha |
  7. Nichol, Kristy |
  8. Hansbro, Nicole G. |
  9. Gearing, Linden J. |
  10. Hertzog, Paul J. |
  11. Gallego-Ortega, David |
  12. Britton, Warwick J. |
  13. Saunders, Bernadette M. |
  14. Wark, Peter A. |
  15. Faiz, Alen |
  16. Hansbro, Philip M. |
1000 Erscheinungsjahr 2022
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2022-09-15
1000 Erschienen in
1000 Quellenangabe
  • 206(6):712-729
1000 Copyrightjahr
  • 2022
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1164/rccm.202108-1901OC |
1000 Ergänzendes Material
  • https://www.atsjournals.org/doi/suppl/10.1164/rccm.202108-1901OC |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • RATIONALE: Patients with chronic obstructive pulmonary disease (COPD) develop more severe coronavirus disease (COVID-19); however, it is unclear whether they are more susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and what mechanisms are responsible for severe disease. OBJECTIVES: To determine whether SARS-CoV-2 inoculated primary bronchial epithelial cells (pBECs) from patients with COPD support greater infection and elucidate the effects and mechanisms involved. METHODS: We performed single-cell RNA sequencing analysis on differentiated pBECs from healthy subjects and patients with COPD 7 days after SARS-CoV-2 inoculation. We correlated changes with viral titers, proinflammatory responses, and IFN production. MEASUREMENTS AND MAIN RESULTS: Single-cell RNA sequencing revealed that COPD pBECs had 24-fold greater infection than healthy cells, which was supported by plaque assays. Club/goblet and basal cells were the predominant populations infected and expressed mRNAs involved in viral replication. Proteases involved in SARS-CoV-2 entry/infection (TMPRSS2 and CTSB) were increased, and protease inhibitors (serpins) were downregulated more so in COPD. Inflammatory cytokines linked to COPD exacerbations and severe COVID-19 were increased, whereas IFN responses were blunted. Coexpression analysis revealed a prominent population of club/goblet cells with high type 1/2 IFN responses that were important drivers of immune responses to infection in both healthy and COPD pBECs. Therapeutic inhibition of proteases and inflammatory imbalances reduced viral titers and cytokine responses, particularly in COPD pBECs. CONCLUSIONS: COPD pBECs are more susceptible to SARS-CoV-2 infection because of increases in coreceptor expression and protease imbalances and have greater inflammatory responses. A prominent cluster of IFN-responsive club/goblet cells emerges during infection, which may be important drivers of immunity. Therapeutic interventions suppress SARS-CoV-2 replication and consequent inflammation.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal COPD
lokal single-cell RNA sequenzing
lokal interferon
lokal protease
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/Sm9oYW5zZW4sIE1hdHQgRC4=|https://frl.publisso.de/adhoc/uri/TWFoYnViLCBSYXNoYWQgTS4=|https://frl.publisso.de/adhoc/uri/SWRyZWVzLCBTb2JpYQ==|https://frl.publisso.de/adhoc/uri/Tmd1eWVuLCBEdWMgSC4=|https://frl.publisso.de/adhoc/uri/TWllbWN6eWssIFN0ZWZhbg==|https://frl.publisso.de/adhoc/uri/UGF0aGluYXlha2UsIFByYWJ1ZGRoYQ==|https://frl.publisso.de/adhoc/uri/TmljaG9sLCBLcmlzdHk=|https://frl.publisso.de/adhoc/uri/SGFuc2JybywgTmljb2xlIEcu|https://frl.publisso.de/adhoc/uri/R2VhcmluZywgTGluZGVuIEou|https://frl.publisso.de/adhoc/uri/SGVydHpvZywgUGF1bCBKLg==|https://frl.publisso.de/adhoc/uri/R2FsbGVnby1PcnRlZ2EsIERhdmlk|https://frl.publisso.de/adhoc/uri/QnJpdHRvbiwgV2Fyd2ljayBKLg==|https://frl.publisso.de/adhoc/uri/U2F1bmRlcnMsIEJlcm5hZGV0dGUgTS4=|https://frl.publisso.de/adhoc/uri/V2FyaywgUGV0ZXIgQS4=|https://frl.publisso.de/adhoc/uri/RmFpeiwgQWxlbg==|https://frl.publisso.de/adhoc/uri/SGFuc2JybywgUGhpbGlwIE0u
1000 Label
1000 Förderer
  1. Rainbow Foundation |
  2. National Health and Medical Research Council |
  3. University of Technology Sydney |
  4. Australia |
1000 Fördernummer
  1. -
  2. 2011467;117534
  3. 2007221
  4. -
1000 Förderprogramm
  1. -
  2. -
  3. Medical Research Fund
  4. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Rainbow Foundation |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer National Health and Medical Research Council |
    1000 Förderprogramm -
    1000 Fördernummer 2011467;117534
  3. 1000 joinedFunding-child
    1000 Förderer University of Technology Sydney |
    1000 Förderprogramm Medical Research Fund
    1000 Fördernummer 2007221
  4. 1000 joinedFunding-child
    1000 Förderer Australia |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6435426.rdf
1000 Erstellt am 2022-10-11T16:10:19.233+0200
1000 Erstellt von 329
1000 beschreibt frl:6435426
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet 2023-10-20T13:21:05.980+0200
1000 Objekt bearb. Thu Apr 27 11:47:50 CEST 2023
1000 Vgl. frl:6435426
1000 Oai Id
  1. oai:frl.publisso.de:frl:6435426 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source